Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3

Conditions

Polycystic Ovary Syndrome 3Obesity 3Dyspnea 2Neoplasms 1Hyperandrogenism 1Hematologic Diseases 1

Interventions

Metformin 17Liraglutide 5semaglutide 3Exercise 3Exenatide 3Diet, Mediterranean 3Dexamethasone 3Caloric Restriction 3Ovidrel 2Mindfulness-Based Stress Reduction 2Hydrocortisone 2Electroacupuncture 2Docosahexaenoic Acids 2Diet 2Cosyntropin 2sibutramine 1penclomedine 1mirabegron 1lime 1licogliflozin 1dapagliflozin 1Vitamin D 1Utrogestan 1Topiramate 1Tirzepatide 1Therapeutics 1Testosterone 1Surveys and Questionnaires 1Standard of Care 1Spironolactone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Dexamethasone × Other × Clear all
NCT01421797 2023-10-27

JCM022

University of Virginia

Phase NA Unknown
84 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡